Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-12 Purchase |
2021-02-12 6:00 pm |
Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer |
1,000 | $8 | $8,000 | 16,686 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-12 Other |
2021-02-12 6:02 pm |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | SALMON Pharma GmbH 10% Owner |
47,063 | $6.4 | 94,126 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-12 6:01 pm |
N/A 2031-02-12 |
Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-02-12 Other |
2021-02-12 6:00 pm |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer |
7,843 | $6.4 | 16,686 (Direct) |
View |
Ownership |
2021-02-10 08:31 am |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director 10% Owner |
0 | $0 | 843,750 (Indirect) |
View |
Ownership |
2021-02-10 08:31 am |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | Arcturus Therapeutics Holdings Inc. 10% Owner |
0 | $0 | 843,750 (Direct) |
View |
Ownership |
2021-02-09 9:17 pm |
2019-01-15 2028-10-01 |
Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer |
0 | $0 | 108,125 (Direct) |
View |
Ownership |
2021-02-09 9:16 pm |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | Levi Ofir Director |
0 | $0 | 196,875 (Direct) |
View |
Ownership |
2021-02-09 9:16 pm |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | Ammer Richard Director 10% Owner |
0 | $0 | 1,476,734 (Indirect) |
View |
Ownership |
2021-02-09 9:15 pm |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | SALMON Pharma GmbH 10% Owner |
0 | $0 | 1,476,734 (Direct) |
View |
Ownership |
2021-02-09 9:14 pm |
2018-10-01 2028-10-01 |
Vallon Pharmaceuticals Inc. | VLON | Toren Penny SVP, Regul Affairs & Prog Mgmt |
0 | $0 | 12,813 (Direct) |
View |